Vanda Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Vanda Pharmaceuticals, Inc. (VNDA)

6.20 -1.23 (-16.55%) USD | NASDAQ | Feb 12, 13:45

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for VNDA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
AbbVie, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
AnaptysBio, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	Upgrade